NSC-645787

N/A

Report date: 2023/05/22 10:16:44

Base Information

Drug NameNSC-645787
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 4 inhibitors
TargetsCyclin-dependent kinase 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A